Helicobacter pylori and risk of upper gastrointestinal bleeding among users of selective serotonin reuptake inhibitors

References

• Dall M, Schaffalitzky de Muckadell OB, Lassen AT, Hansen JM, Hallas J. An association between selective serotonin reuptake inhibitor use and serious upper gastrointestinal bleeding. Clin Gastroenterol Hepatol 2009;7:1314–21.
   PubMed Web of Science ®Google Scholar
• de Abajo FJ, Garcia Rodriguez LA, Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: a population-based case-control study. Br Med J 1999;319:1106–9.
   PubMed Web of Science ®Google Scholar
• van Walraven C, Mamdani MM, Wells PS, Williams JI. Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. BMJ 2001;323:655–8.
   PubMed Web of Science ®Google Scholar
• Dalton SO, Johansen C, Mellemkjaer L, Nørgård B, Sørensen HT, Olsen JH. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med 2003;163:59–64.
   PubMed Web of Science ®Google Scholar
• Tata LJ, Fortun PJ, Hubbard RB, Smeeth L, Hawkey CJ, Smith CJ, Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? Aliment Pharmacol Ther 2005;22:175–81.
   PubMed Web of Science ®Google Scholar
• Helin-Salmivaara A, Huttunen T, Grönroos JM, Klaukka T, Huupponen R. Risk of serious upper gastrointestinal events with concurrent use of NSAIDs and SSRIs: a case-control study in the general population. Eur J Clin Pharmacol 2007;63:403–8.
   PubMed Web of Science ®Google Scholar
• Opatrny L, Delaney JA, Suissa S. Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look. Br J Clin Pharmacol 2008;66:76–81.
   PubMed Web of Science ®Google Scholar
• Lewis JD, Strom BL, Localio AR, Metz DC, Farrar JT, Weinrieb RM, Moderate and high affinity serotonin reuptake inhibitors increase the risk of upper gastrointestinal toxicity. Pharmacoepidemiol Drug Saf 2008;17:328–35.
   PubMedGoogle Scholar
• de Abajo FJ, García-Rodríguez LA. Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents. Arch Gen Psychiatry 2008;65:795–803.
   PubMed Web of Science ®Google Scholar
• Targownik LE, Bolton JM, Metge CJ, Leung S, Sareen J. Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding. Am J Gastroenterol 2009;104:1475–82.
   PubMed Web of Science ®Google Scholar
• Li N, Wallen NH, Ladjevardi M, Hjemdahl P. Effects of serotonin on platelet activation in whole blood. Blood Coagul Fibrinolysis 1997;8:517–23.
   PubMed Web of Science ®Google Scholar
• Skop BP, Brown TM. Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors. Psychosomatics 1996;37:12–16.
   PubMed Web of Science ®Google Scholar
• Javors MA, Houston JP, Tekell JL, Brannan SK, Frazer A. Reduction of platelet serotonin content in depressed patients treated with either paroxetine or desipramine. Int J Neuropsychopharmacol 2000;3:229–35.
   PubMed Web of Science ®Google Scholar
• Jaspersen D. Helicobacter pylori eradication: the best long-term prophylaxis for ulcer bleeding recurrence? Endoscopy 1995;27:622–5.
   PubMed Web of Science ®Google Scholar
• Chan FK, To KF, Wu JC, Yung MY, Leung WK, Kwok T, Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial. Lancet 2002;359:9–13.
   PubMed Web of Science ®Google Scholar
• Aalykke C, Lauritsen JM, Hallas J, Reinholdt S, Krogfelt K, Lauritsen K. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study. Gastroenterology 1999;116:1305–9.
   PubMed Web of Science ®Google Scholar
• Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 2002;359:14–22.
   PubMed Web of Science ®Google Scholar
• Wildner-Christensen M, Møller Hansen J, Schaffalitzky de Muckadell OB. Rates of dyspepsia one year after Helicobacter pylori screening and eradication in a Danish population. Gastroenterology 2003;125:372–9.
   PubMed Web of Science ®Google Scholar
• Gaist D, Sørensen HT, Hallas J. The Danish Prescription Registries. Dan Med Bull 1997;44:445–8.
   PubMed Web of Science ®Google Scholar
• WHO Collaborating Centre for Drug Statistics Methodology. ATC index with DDDs and guidelines for ATC classification and DDD assignment. Oslo: Norwegian Institute of Public Health, 2006.
   Google Scholar
• Frank L. Epidemiology. When an entire country is a cohort. Science 2000;287:2398–9.
   PubMed Web of Science ®Google Scholar
• Rosholm J-U, Andersen M, Gram LF. Are there differences in the use of selective serotonin reuptake inhibitors and tricyclic antidepressants? A prescription database study. Eur J Clin Pharmacol 2001;56:923–9.
   PubMed Web of Science ®Google Scholar
• Rogge J, Wagner D, Carrico R, Glowinski EA, Mahoney SJ, Boguslaski RC, Evaluation of a new urease reagent strip for detection of Helicobacter pylori in gastric biopsy specimens. Am J Gastroenterol 1995;90:1965–8.
   PubMedGoogle Scholar
• Lassen AT. Helicobacter pylori eradication in management of dyspepsia. Ph.D. Thesis. Faculty of Health Science, University of Southern Denmark, 2000.
   Google Scholar
• Schrier WH, Schoengold RJ, Baker JT, Norell JL, Jaseph CL, Okin Y, Development of FlexSure HP–an immunochromatographic method to detect antibodies against Helicobacter pylori. Clin Chem 1998;44:293–8.
   PubMedGoogle Scholar
• Williams RL. A note on robust variance estimation for cluster-correlated data. Biometrics 2000;56:645–6.
   PubMed Web of Science ®Google Scholar
• Release 10.1. StataCorp, 4905 Lakeway Drive, College Station, Texas 77845 USA. http://www.stata.com.
   Google Scholar
• Vestergård A, Bredahl K, Schaffalitzky de Muckadell OB, Pedersen OB, Hansen JM. Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid. Ugeskr Laeger 2009;171:235–9.
   PubMedGoogle Scholar
• van Leeuwen AW, de Nooijer P, Hop WC. Screening for cervical carcinoma. Cancer 2005;105:270–6.
   PubMed Web of Science ®Google Scholar
• Reubsaet A, van Osch LA, de Vries H, de Coul MR, Lechner L. Some signals cannot wait: effects of a national campaign on early detection of cancer among Dutch adults (>55 years). Cancer Epidemiol 2009;33:194–200.
   PubMedGoogle Scholar
• Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet 1992;339:896–7.
   PubMed Web of Science ®Google Scholar
• Moayyedi P, Axon AT, Feltbower R, Duffett S, Crocombe W, Braunholtz D, Relation of adult lifestyle and socioeconomic factors to the prevalence of Helicobacter pylori infection. Int J Epidemiol 2002;31:624–31.
   PubMed Web of Science ®Google Scholar
• Vergara M, Catalán M, Gisbert JP, Calvet X. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users. Aliment Pharmacol Ther 2005;21:1411–18.
   PubMed Web of Science ®Google Scholar
• Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R, Talley NJ, Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol 2009;24:1587–600.
   PubMed Web of Science ®Google Scholar
• You JH, Lau W, Lee IY, Yung M, Ching JY, Chan FK, Helicobacter pylori eradication prior to initiation of long-term non-steroidal anti-inflammatory drug therapy in Chinese patients-a cost-effectiveness analysis. Int J Clin Pharmacol Ther 2006;44:149–53.
   PubMed Web of Science ®Google Scholar